A clinical study showed that infliximab, a TNFa blocking antibody, induces apoptosis in activated T cells isolated from the lamina propria of steroid-refractory Crohn’s disease patients, presumably due to anti-apoptotic NF-κB signaling withdrawal (84). This evidence concerns the gene NFKB1 and Crohn disease.